Fig. 4From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approacha Pre-NAC mammogram; UOQ focal asymmetry. b Post-NAC mammogram; reduction in size. c Pre-NAC CESM; an enhancing mass. d Post-NAC CESM CC view showing type I shrinkage. Both RECIST 1.1 and combined response evaluation; partial responder. Pathology; Miller-Payne grade 5Back to article page